1. Home
  2. WHF vs STIM Comparison

WHF vs STIM Comparison

Compare WHF & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WHF

WhiteHorse Finance Inc.

HOLD

Current Price

$6.75

Market Cap

144.8M

Sector

Finance

ML Signal

HOLD

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$1.54

Market Cap

140.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHF
STIM
Founded
2011
2003
Country
United States
United States
Employees
3
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
144.8M
140.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
WHF
STIM
Price
$6.75
$1.54
Analyst Decision
Sell
Strong Buy
Analyst Count
2
1
Target Price
$7.75
$3.00
AVG Volume (30 Days)
97.8K
3.0M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
13.67%
N/A
EPS Growth
N/A
57.25
EPS
N/A
N/A
Revenue
N/A
$52,776,000.00
Revenue This Year
N/A
$11.10
Revenue Next Year
N/A
$11.92
P/E Ratio
$15.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.07
$0.80
52 Week High
$9.66
$4.84

Technical Indicators

Market Signals
Indicator
WHF
STIM
Relative Strength Index (RSI) 35.34 54.76
Support Level $6.44 $1.21
Resistance Level $7.24 $1.75
Average True Range (ATR) 0.22 0.15
MACD -0.07 0.01
Stochastic Oscillator 29.46 81.65

Price Performance

Historical Comparison
WHF
STIM

About WHF WhiteHorse Finance Inc.

WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

Share on Social Networks: